awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q21285014-488AC028-BE67-4956-9CDF-30F0ECC95030
Q21285014-488AC028-BE67-4956-9CDF-30F0ECC95030
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21285014-488AC028-BE67-4956-9CDF-30F0ECC95030
Targeted therapies in sarcomas: challenging the challenge
P2860
Q21285014-488AC028-BE67-4956-9CDF-30F0ECC95030
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21285014-488AC028-BE67-4956-9CDF-30F0ECC95030
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c79d70be3c7332acdb22beb19ac99f4d6dedb1c3
P2860
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.